| Nader Makram Mina, MD | |
|
4201 Saint Antoine St, Uhc Cpap Clinic Suite 5v, Detroit, MI 48201-2153 | |
| (313) 745-4525 | |
| (313) 745-8725 |
| Full Name | Nader Makram Mina |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 21 Years |
| Location | 4201 Saint Antoine St, Detroit, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295997542 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beaumont Hospital Royal Oak | Royal oak, MI | Hospital |
| Beaumont Hospital, Troy | Troy, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beaumont Medical Group- Specialty Services | 7214299866 | 787 |
News Archive
Mental health services in England and Wales have been accused of being institutionally racist.
An interview with The Drake Foundation, discussing the short and long-term effects of concussions obtained during contact sports such as football and rugby.
New research shows that Antiretroviral Therapy (ART) continues to dramatically reduce rates of mortality from HIV infection in high-income countries, such that non-AIDS-related deaths exceed AIDS deaths after approximately four years of taking ART.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has entered into an agreement with Medtronic, Inc., a leader in medical technologies to improve the treatment of chronic diseases, including cardiac rhythm disorders, to collaborate on ARCA's proposed clinical trial, known as GENETIC-AF, of its lead developmental drug Gencaro (bucindolol hydrochloride).
› Verified 1 days ago
| Entity Name | William Beaumont Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083833875 PECOS PAC ID: 9335051093 Enrollment ID: O20031104000279 |
News Archive
Mental health services in England and Wales have been accused of being institutionally racist.
An interview with The Drake Foundation, discussing the short and long-term effects of concussions obtained during contact sports such as football and rugby.
New research shows that Antiretroviral Therapy (ART) continues to dramatically reduce rates of mortality from HIV infection in high-income countries, such that non-AIDS-related deaths exceed AIDS deaths after approximately four years of taking ART.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has entered into an agreement with Medtronic, Inc., a leader in medical technologies to improve the treatment of chronic diseases, including cardiac rhythm disorders, to collaborate on ARCA's proposed clinical trial, known as GENETIC-AF, of its lead developmental drug Gencaro (bucindolol hydrochloride).
› Verified 1 days ago
| Entity Name | University Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447299797 PECOS PAC ID: 8628087681 Enrollment ID: O20060419000518 |
News Archive
Mental health services in England and Wales have been accused of being institutionally racist.
An interview with The Drake Foundation, discussing the short and long-term effects of concussions obtained during contact sports such as football and rugby.
New research shows that Antiretroviral Therapy (ART) continues to dramatically reduce rates of mortality from HIV infection in high-income countries, such that non-AIDS-related deaths exceed AIDS deaths after approximately four years of taking ART.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has entered into an agreement with Medtronic, Inc., a leader in medical technologies to improve the treatment of chronic diseases, including cardiac rhythm disorders, to collaborate on ARCA's proposed clinical trial, known as GENETIC-AF, of its lead developmental drug Gencaro (bucindolol hydrochloride).
› Verified 1 days ago
| Entity Name | Beaumont Medical Group- Specialty Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578072906 PECOS PAC ID: 7214299866 Enrollment ID: O20180320002549 |
News Archive
Mental health services in England and Wales have been accused of being institutionally racist.
An interview with The Drake Foundation, discussing the short and long-term effects of concussions obtained during contact sports such as football and rugby.
New research shows that Antiretroviral Therapy (ART) continues to dramatically reduce rates of mortality from HIV infection in high-income countries, such that non-AIDS-related deaths exceed AIDS deaths after approximately four years of taking ART.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has entered into an agreement with Medtronic, Inc., a leader in medical technologies to improve the treatment of chronic diseases, including cardiac rhythm disorders, to collaborate on ARCA's proposed clinical trial, known as GENETIC-AF, of its lead developmental drug Gencaro (bucindolol hydrochloride).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nader Makram Mina, MD 1420 Stephenson Hwy, Suite 400-credentialing, Troy, MI 48083-1189 Ph: (248) 581-5972 | Nader Makram Mina, MD 4201 Saint Antoine St, Uhc Cpap Clinic Suite 5v, Detroit, MI 48201-2153 Ph: (313) 745-4525 |
News Archive
Mental health services in England and Wales have been accused of being institutionally racist.
An interview with The Drake Foundation, discussing the short and long-term effects of concussions obtained during contact sports such as football and rugby.
New research shows that Antiretroviral Therapy (ART) continues to dramatically reduce rates of mortality from HIV infection in high-income countries, such that non-AIDS-related deaths exceed AIDS deaths after approximately four years of taking ART.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has entered into an agreement with Medtronic, Inc., a leader in medical technologies to improve the treatment of chronic diseases, including cardiac rhythm disorders, to collaborate on ARCA's proposed clinical trial, known as GENETIC-AF, of its lead developmental drug Gencaro (bucindolol hydrochloride).
› Verified 1 days ago
Dr. Saba Alan Francis, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 50 E Canfield St, Detroit, MI 48201 Phone: 313-745-4525 | |
Dr. Roopkiranjot Kahlon, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4201 Saint Antoine St, University Health Center 2e, Detroit, MI 48201 Phone: 313-745-4525 | |
Avi Cohen, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 | |
Waleed Obaid, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6071 W Outer Dr, Detroit, MI 48235 Phone: 313-966-3250 | |
Lindsey Aurora, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 | |
Alexander Garbarino, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 | |
Maria Diab, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 800-653-6568 Fax: 313-876-1305 |